This NINDS grant provides renewal funding for Small Business Innovation Research (SBIR) Phase II projects. Its purpose is to support clinical trials and clinical research focusing on products aligned with the National Institute of Neurological Disorders and Stroke’s mission, including drugs, devices, and therapies. This funding aims to help small business concerns (SBCs) commercialize previously NIH SBIR/STTR Phase II-funded projects, particularly those requiring capital-intensive clinical trials. Applicants must demonstrate partnerships with third-party investors or strategic partners. A Commercialization Plan is mandatory, detailing independent third-party funding that matches or exceeds the requested NINDS funds, facilitating the transition to market.
Opportunity ID: 355039
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-24-221 |
| Funding Opportunity Title: | NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 20, 2024 |
| Last Updated Date: | Jun 20, 2024 |
| Original Closing Date for Applications: | Apr 05, 2027 |
| Current Closing Date for Applications: | Apr 05, 2027 |
| Archive Date: | May 11, 2027 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | (Reissue of PAR-18-665) This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support clinical trials for projects that were previously funded by NIH SBIR and STTR Phase II awards. The projects must focus on products related to the mission and goals of the National Institute of Neurological Disorders and Stroke (NINDS) and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Since conducting the clinical trials needed for commercialization may be capital-intensive, the FOA aims to facilitate the transition of SBIR Phase II projects to the commercialization stage by promoting partnerships between NIH’s SBIR/STTR awardees and third-party investors and/or strategic partners. Consistent with the goals of this funding initiative and as required by the SF424 instructions for all SBIR Phase II applications, applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will equal or exceed the NINDS funds being requested throughout the SBIR Phase IIB project period. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-24-221.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 355039 Full Announcement-PAR-24-221 -> PAR-24-221-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00287102 | Aug 05, 2024 | Jan 24, 2025 | View | |
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289102 | Nov 26, 2024 | Apr 05, 2027 | View |
Package 1
Mandatory forms
355039 RR_SF424_5_0-5.0.pdf
355039 PHS398_CoverPageSupplement_5_0-5.0.pdf
355039 RR_OtherProjectInfo_1_4-1.4.pdf
355039 PerformanceSite_4_0-4.0.pdf
355039 RR_KeyPersonExpanded_4_0-4.0.pdf
355039 RR_Budget_3_0-3.0.pdf
355039 PHS398_ResearchPlan_5_0-5.0.pdf
355039 SBIR_STTR_Information_3_0-3.0.pdf
355039 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
355039 RR_SubawardBudget30_3_0-3.0.pdf
355039 PHS_AssignmentRequestForm_4_0-4.0.pdf
Package 2
Mandatory forms
355039 RR_SF424_5_0-5.0.pdf
355039 PHS398_CoverPageSupplement_5_0-5.0.pdf
355039 RR_OtherProjectInfo_1_4-1.4.pdf
355039 PerformanceSite_4_0-4.0.pdf
355039 RR_KeyPersonExpanded_4_0-4.0.pdf
355039 RR_Budget_3_0-3.0.pdf
355039 PHS398_ResearchPlan_5_0-5.0.pdf
355039 SBIR_STTR_Information_3_0-3.0.pdf
355039 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
355039 RR_SubawardBudget30_3_0-3.0.pdf
355039 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
